Key facts
- This page summarizes Jill M. Quigley's Form 4 filing for Passage BIO, Inc. (PASG).
- 3 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 10 Dec 2021, 16:30.
Jill M. Quigley - 08 Dec 2021 Form 4 Insider Report for Passage BIO, Inc. (PASG)
- Reporting relationship
- Chief Operating Officer
- Issuer ticker
- PASG
- Reported as of
- 08 Dec 2021
- Net transaction value
- +$16,554
- SEC form
- 4
- Accepted by SEC
- 10 Dec 2021, 16:30:22 UTC
- Prior SEC filing
- 30 Sep 2021
- Next SEC filing
- 21 Jun 2022
- Source filing
- View source filing
- Reporting owner signature
- /s/ Edgar Cale, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Jill M. Quigley filed Form 4 for Passage BIO, Inc. (PASG) on 10 Dec 2021.
Change
- Previous filing in this sequence was filed on 30 Sep 2021.
- Current net transaction value: +$16,554.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
PASG
transaction
Common Stock
Options Exercise
- Transaction value
- $16,554
- Shares
- +71,975
- Change %
- +24%
- Price
- $0.2300
- Shares after
- 368,754
- Date
- 08 Dec 2021
- Ownership
- Direct
- Footnotes
- F1, F2
PASG
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 3,608
- Date
- 08 Dec 2021
- Ownership
- By Spouse
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
PASG
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -11,193
- Change %
- -75%
- Price
- $0.000000
- Shares after
- 3,729
- Date
- 08 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 11,193
- Exercise price
- $0.2300
- Footnotes
- F3
PASG
transaction
Derivative
Employee Stock Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -60,782
- Change %
- -69%
- Price
- $0.000000
- Shares after
- 27,626
- Date
- 08 Dec 2021
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 60,782
- Exercise price
- $0.2300
- Footnotes
- F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 4 footnotes
Footnote F1
Includes 367,259 of common stock, of which 88,488 shares are unvested and subject to repurchase by the Issuer if the reporting person ceases to provide services to the Issuer prior to the vesting of the shares.
Footnote F2
Includes 1,495 shares acquired under the 2020 Employee Stock Purchase Plan on May 14, 2021.
Footnote F3
The option vested as to 25% of the total shares on November 12, 2019 and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on November 12, 2022, subject to the reporting person's provision of service to the issuer on each vesting date.
Footnote F4
The option vests as to 25% of the total shares on May 8, 2020 and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on May 8, 2023 subject to the reporting person's provision of service to the issuer on each vesting date.